CVS appoints new CMO

CVS Health has tapped Sree Chaguturu, MD, as its new executive vice president and chief medical officer, effective immediately. 

In this new role Chaguturu will have oversight for the CVS Health Medical Affairs organization spanning Aetna, CVS Caremark, CVS Pharmacy, MinuteClinic, Women’s Health and Genomics, Patient Safety, Health Equity, and Data and Analytics. He will be responsible for advancing the highest possible clinical quality standards, increasing access to care, improving patient outcomes and reducing overall healthcare costs across the enterprise.

Chaguturu, currently a practicing internal medicine physician at Massachusetts General Hospital, previously served as CMO for CVS Caremark, the pharmacy benefits manager business of CVS Health. Prior to joining CVS, Chaguturu served as chief population health officer and Mass General Brigham, the largest healthcare system in Massachusetts, where he led the system’s accountable care organization and numerous clinical care delivery and innovation programs. He also previously held roles at McKinsey and Company. 

“Since joining CVS Health in 2019, Sree has been an influential and respected clinical leader, serving as a trusted advisor for clients, members, and colleagues,” CVS Health President and CEO Karen S. Lynch said in the announcement. “He played a critical role in the company’s pandemic response, including leading Return Ready, our employer COVID-19 testing and vaccination offering."

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”